Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

375 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Update on the epidemiology and management of cryptococcal meningitis.
Desalermos A, Kourkoumpetis TK, Mylonakis E. Desalermos A, et al. Expert Opin Pharmacother. 2012 Apr;13(6):783-9. doi: 10.1517/14656566.2012.658773. Epub 2012 Mar 19. Expert Opin Pharmacother. 2012. PMID: 22424297
Whole animal HTS of small molecules for antifungal compounds.
Muhammed M, Arvanitis M, Mylonakis E. Muhammed M, et al. Expert Opin Drug Discov. 2016;11(2):177-84. doi: 10.1517/17460441.2016.1122591. Epub 2015 Dec 14. Expert Opin Drug Discov. 2016. PMID: 26593386 Review.
Antifungal use in HIV infection.
Marty F, Mylonakis E. Marty F, et al. Expert Opin Pharmacother. 2002 Feb;3(2):91-102. doi: 10.1517/14656566.3.2.91. Expert Opin Pharmacother. 2002. PMID: 11829723 Review.
Epidemiology and management of cryptococcal meningitis: developments and challenges.
Pukkila-Worley R, Mylonakis E. Pukkila-Worley R, et al. Expert Opin Pharmacother. 2008 Mar;9(4):551-60. doi: 10.1517/14656566.9.4.551. Expert Opin Pharmacother. 2008. PMID: 18312157 Review.
Posaconazole: a new broad-spectrum antifungal agent.
Kwon DS, Mylonakis E. Kwon DS, et al. Expert Opin Pharmacother. 2007 Jun;8(8):1167-78. doi: 10.1517/14656566.8.8.1167. Expert Opin Pharmacother. 2007. PMID: 17516880 Review.
Developments in the treatment of candidiasis: more choices and new challenges.
Aperis G, Myriounis N, Spanakis EK, Mylonakis E. Aperis G, et al. Expert Opin Investig Drugs. 2006 Nov;15(11):1319-36. doi: 10.1517/13543784.15.11.1319. Expert Opin Investig Drugs. 2006. PMID: 17040194 Review.
Galleria mellonella as a model system to study Cryptococcus neoformans pathogenesis.
Mylonakis E, Moreno R, El Khoury JB, Idnurm A, Heitman J, Calderwood SB, Ausubel FM, Diener A. Mylonakis E, et al. Infect Immun. 2005 Jul;73(7):3842-50. doi: 10.1128/IAI.73.7.3842-3850.2005. Infect Immun. 2005. PMID: 15972469 Free PMC article.
Caenorhabditis elegans-based model systems for antifungal drug discovery.
Anastassopoulou CG, Fuchs BB, Mylonakis E. Anastassopoulou CG, et al. Curr Pharm Des. 2011;17(13):1225-33. doi: 10.2174/138161211795703753. Curr Pharm Des. 2011. PMID: 21470110 Free PMC article. Review.
Structure-activity relationships of pyrazole-4-carbodithioates as antibacterials against methicillin-resistant Staphylococcus aureus.
Majed H, Johnston T, Kelso C, Monachino E, Jergic S, Dixon NE, Mylonakis E, Kelso MJ. Majed H, et al. Bioorg Med Chem Lett. 2018 Dec 1;28(22):3526-3528. doi: 10.1016/j.bmcl.2018.09.038. Epub 2018 Oct 3. Bioorg Med Chem Lett. 2018. PMID: 30297281 Free PMC article.
Antibacterial properties of 3-(phenylsulfonyl)-2-pyrazinecarbonitrile.
Rajamuthiah R, Jayamani E, Majed H, Conery AL, Kim W, Kwon B, Fuchs BB, Kelso MJ, Ausubel FM, Mylonakis E. Rajamuthiah R, et al. Bioorg Med Chem Lett. 2015 Nov 15;25(22):5203-7. doi: 10.1016/j.bmcl.2015.09.066. Epub 2015 Sep 30. Bioorg Med Chem Lett. 2015. PMID: 26459212 Free PMC article.
375 results
Jump to page
Feedback